المؤلفون: Margaryan, Tigran, Elliott, Mackenna, Sanai, Nader, Tovmasyan, Artak

المصدر: Translational Neuroscience

مصطلحات موضوعية: Abemaciclib, Brain tumor penetration, Equilibrium dialysis, LC-MS/MS, LY3214996

Relation: https://scholar.barrowneuro.org/neurobiology/2287; https://doi.org/10.1016/j.jpha.2022.05.003

الاتاحة: https://scholar.barrowneuro.org/neurobiology/2287
https://doi.org/10.1016/j.jpha.2022.05.003

المؤلفون: Chen W, Wu S, Huang Y, Zhang T, Dong H, Zheng X, Chen T, Gong X, Liu G, Zhao X

المصدر: OncoTargets and Therapy, Vol Volume 14, Pp 4791-4804 (2021)

مصطلحات موضوعية: osteosarcoma, met, pha-665752, erk signaling, ly3214996, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Relation: https://www.dovepress.com/a-c-met-inhibitor-suppresses-osteosarcoma-progression-via-the-erk12-pa-peer-reviewed-fulltext-article-OTT; https://doaj.org/toc/1178-6930; https://doaj.org/article/2dcf627156854f489f6e8f16fb2bf54b

الاتاحة: https://doaj.org/article/2dcf627156854f489f6e8f16fb2bf54b

المؤلفون: Xing Zhao, Tingting Zhang, Gang Liu, Su Wu, Weijie Chen, Xiaokang Gong, Yang Huang, Tao Chen, Xing Zheng, Hao Dong

المصدر: OncoTargets and therapy

مصطلحات موضوعية: musculoskeletal diseases, business.industry, Cell growth, PHA-665752, medicine.disease, OncoTargets and Therapy, Metastasis, c-Met inhibitor, ERK signaling, Oncology, Gentamicin protection assay, In vivo, Apoptosis, osteosarcoma, LY3214996, Cancer research, Met, Medicine, Osteosarcoma, Pharmacology (medical), Signal transduction, business, neoplasms, Original Research

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5216dc3b985df3968ca20faa214635e4
https://pubmed.ncbi.nlm.nih.gov/34531665

المؤلفون: Shuping Zhou, Xiaolong Tang, Amin Li, Xueke Liu, Shuyu Cai, Yongfang Ma, Yinci Zhang, Ruyue Xu, Li Song, Weiya Cao, Yinghai Xie

المصدر: International Journal of Medical Sciences

مصطلحات موضوعية: Sorafenib, MAPK/ERK pathway, Carcinoma, Hepatocellular, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Growth factor receptor, Cell Line, Tumor, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, heterocyclic compounds, Ras/Raf/MAPK pathway, Pyrroles, Protein kinase B, Protein Kinase Inhibitors, neoplasms, PI3K/AKT/mTOR pathway, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, business.industry, Cell growth, acquired resistance, Liver Neoplasms, Drug Synergism, General Medicine, hepatocellular carcinoma, Cell cycle, medicine.disease, female genital diseases and pregnancy complications, digestive system diseases, Drug Resistance, Neoplasm, Hepatocellular carcinoma, LY3214996, Cancer research, Pyrazoles, 030211 gastroenterology & hepatology, business, medicine.drug, Research Paper

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7b8ea3bca715ebf2fce2cb917b37f3
https://doi.org/10.21203/rs.3.rs-49605/v1

المؤلفون: William T. McMillen, Lisa Kindler, Shripad V. Bhagwat, Ramon V. Tiu, Wenjuan Wu, Sheng-Bin Peng, Christoph Reinhard, Sean Buchanan, Sajan Joseph

المصدر: Cancer Research. 79:LB-083

مصطلحات موضوعية: MAPK/ERK pathway, Cancer Research, business.industry, Colorectal cancer, non-small cell lung cancer (NSCLC), Cancer, medicine.disease, medicine.disease_cause, Metastasis, Oncology, ERK1/2 Inhibitor LY3214996, Cancer cell, medicine, Cancer research, KRAS, business, neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8515dc7bcfe215979c26a8bd8c276dc2
https://doi.org/10.1158/1538-7445.am2019-lb-083

المؤلفون: Shripad V. Bhagwat, Wenjuan Wu, William T. McMillen, Sean Buchanan, Sajan Joseph, Christoph Reinhard, Michelle L. Swearingen, Beverly L. Falcon, Bonita D. Jones, Ramon V. Tiu, Sheng-Bin Peng

المصدر: Cancer Research. 78:LB-185

مصطلحات موضوعية: Cancer Research, Cell growth, business.industry, Cancer, Cell cycle, medicine.disease_cause, medicine.disease, Ramucirumab, Metastasis, Oncology, ERK1/2 Inhibitor LY3214996, medicine, Cancer research, KRAS, business, Lung cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ff79efe5f6302744a9b933c787410e13
https://doi.org/10.1158/1538-7445.am2018-lb-185

المؤلفون: Sheng-Bin Peng, Constance King, Xueqian Gong, Sajan Joseph, William T. McMillen, Christoph Reinhard, Julie Stewart, Beverly L. Falcon, Jason Manro, Susan E. Pratt, Robert S. Flack, Richard Beckman, Wenjuan Wu, Bonita D. Jones, Sean Buchanan, Ramon V. Tiu, Shripad V. Bhagwat

المصدر: Cancer Research. 77:317-317

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Cancer, non-small cell lung cancer (NSCLC), Cell cycle, medicine.disease_cause, medicine.disease, respiratory tract diseases, Metastasis, Tumor progression, ERK1/2 Inhibitor LY3214996, Internal medicine, medicine, biology.protein, KRAS, Cyclin-dependent kinase 6, business, neoplasms

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::07a3a4fcccb4ed8718a1eb2c8e39c983
https://doi.org/10.1158/1538-7445.am2017-317